Stock Track | Soleno Therapeutics Soars 5.43% in Post-Market Trading After Wells Fargo Maintains Overweight Rating

Stock Track02-28 05:34

Soleno Therapeutics (SLNO) experienced a significant surge of 5.43% in post-market trading on Friday. The after-hours movement followed the stock's regular session activity.

The sharp increase appears to be a direct reaction to analyst coverage from Wells Fargo, which maintained its Overweight rating on the biotechnology company. Analyst ratings, especially from major financial institutions, are closely watched by investors and can significantly influence trading sentiment and stock valuation.

Maintaining an Overweight rating typically signals that analysts expect the stock to outperform the market or its sector average over a specified period, which often prompts positive investor reaction and buying activity in extended trading sessions.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1129164987?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-28 05:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1129164987","market":"hk","top_or_hot":-1,"title":"Stock Track | Soleno Therapeutics Soars 5.43% in Post-Market Trading After Wells Fargo Maintains Overweight Rating","media":"Stock Track","content":"<p>Soleno Therapeutics (SLNO) experienced a significant surge of 5.43% in post-market trading on Friday. The after-hours movement followed the stock's regular session activity.</p><p>The sharp increase appears to be a direct reaction to analyst coverage from Wells Fargo, which maintained its Overweight rating on the biotechnology company. Analyst ratings, especially from major financial institutions, are closely watched by investors and can significantly influence trading sentiment and stock valuation.</p><p>Maintaining an Overweight rating typically signals that analysts expect the stock to outperform the market or its sector average over a specified period, which often prompts positive investor reaction and buying activity in extended trading sessions.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Soleno Therapeutics Soars 5.43% in Post-Market Trading After Wells Fargo Maintains Overweight Rating</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Soleno Therapeutics Soars 5.43% in Post-Market Trading After Wells Fargo Maintains Overweight Rating\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-28 05:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Soleno Therapeutics (SLNO) experienced a significant surge of 5.43% in post-market trading on Friday. The after-hours movement followed the stock's regular session activity.</p><p>The sharp increase appears to be a direct reaction to analyst coverage from Wells Fargo, which maintained its Overweight rating on the biotechnology company. Analyst ratings, especially from major financial institutions, are closely watched by investors and can significantly influence trading sentiment and stock valuation.</p><p>Maintaining an Overweight rating typically signals that analysts expect the stock to outperform the market or its sector average over a specified period, which often prompts positive investor reaction and buying activity in extended trading sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SLNO","symbol_name":"Soleno Therapeutics","start_time":0,"source_url":"","article_id":"1129164987","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1129164987","pubTimestamp":1772228081,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Soleno Therapeutics (SLNO) experienced a significant surge of 5.43% in post-market trading on Friday. The after-hours movement followed the stock's regular session activity.The sharp increase appears...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SLNO":"Soleno Therapeutics"},"translate_title":"个股追踪|富国银行维持跑赢大盘评级后Soleno Therapeutics盘后大涨5.43%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SLNO":1},"content_text":"Soleno Therapeutics (SLNO) experienced a significant surge of 5.43% in post-market trading on Friday. The after-hours movement followed the stock's regular session activity.The sharp increase appears to be a direct reaction to analyst coverage from Wells Fargo, which maintained its Overweight rating on the biotechnology company. Analyst ratings, especially from major financial institutions, are closely watched by investors and can significantly influence trading sentiment and stock valuation.Maintaining an Overweight rating typically signals that analysts expect the stock to outperform the market or its sector average over a specified period, which often prompts positive investor reaction and buying activity in extended trading sessions.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1129164987","isCrawlerRequest":true}